(Q82548914)
Statements
Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light (English)
Giacomo Duchini
Wolfgang Bäumler
Andreas J Bircher
scientific article published on 01 December 2011